97 related articles for article (PubMed ID: 20659529)
1. Reversible phosphorylation in haematological malignancies: potential role for protein tyrosine phosphatases in treatment?
Ruela-de-Sousa RR; Queiroz KC; Peppelenbosch MP; Fuhler GM
Biochim Biophys Acta; 2010 Dec; 1806(2):287-303. PubMed ID: 20659529
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatases in T cell physiology.
Mustelin T; Alonso A; Bottini N; Huynh H; Rahmouni S; Nika K; Louis-dit-Sully C; Tautz L; Togo SH; Bruckner S; Mena-Duran AV; al-Khouri AM
Mol Immunol; 2004 Jul; 41(6-7):687-700. PubMed ID: 15220004
[TBL] [Abstract][Full Text] [Related]
3. Positive and negative regulation of leukocyte activation by protein tyrosine phosphatases.
Thomas ML
Semin Immunol; 1995 Aug; 7(4):279-88. PubMed ID: 8520032
[TBL] [Abstract][Full Text] [Related]
4. Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies.
Zhu N; Xiao H; Wang LM; Fu S; Zhao C; Huang H
Future Oncol; 2015; 11(4):659-73. PubMed ID: 25686120
[TBL] [Abstract][Full Text] [Related]
5. Regulation of basal tyrosine phosphorylation of the B cell antigen receptor complex by the protein tyrosine phosphatase, CD45.
Lin J; Brown VK; Justement LB
J Immunol; 1992 Nov; 149(10):3182-90. PubMed ID: 1431097
[TBL] [Abstract][Full Text] [Related]
6. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
7. Altered regulation of SHP-2 and PTP 1B tyrosine phosphatases in cystic kidneys from bcl-2 -/- mice.
Sorenson CM; Sheibani N
Am J Physiol Renal Physiol; 2002 Mar; 282(3):F442-50. PubMed ID: 11832424
[TBL] [Abstract][Full Text] [Related]
8. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
9. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development.
Trowbridge IS; Thomas ML
Annu Rev Immunol; 1994; 12():85-116. PubMed ID: 8011300
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
11. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.
Denu JM; Tanner KG
Biochemistry; 1998 Apr; 37(16):5633-42. PubMed ID: 9548949
[TBL] [Abstract][Full Text] [Related]
12. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.
Greer SF; Justement LB
J Immunol; 1999 May; 162(9):5278-86. PubMed ID: 10228003
[TBL] [Abstract][Full Text] [Related]
13. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
Gadina M; Sudarshan C; O'Shea JJ
J Immunol; 1999 Feb; 162(4):2081-6. PubMed ID: 9973481
[TBL] [Abstract][Full Text] [Related]
14. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
15. Localization and down-regulating role of the protein tyrosine phosphatase PTP2C in membrane ruffles of PDGF-stimulated cells.
Cossette LJ; Hoglinger O; Mou L; Shen SH
Exp Cell Res; 1996 Mar; 223(2):459-66. PubMed ID: 8601424
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying the inhibitory effects of arsenic compounds on protein tyrosine phosphatase (PTP).
Rehman K; Chen Z; Wang WW; Wang YW; Sakamoto A; Zhang YF; Naranmandura H; Suzuki N
Toxicol Appl Pharmacol; 2012 Sep; 263(3):273-80. PubMed ID: 22771847
[TBL] [Abstract][Full Text] [Related]
17. The roles of protein tyrosine phosphatases in bone-resorbing osteoclasts.
Shalev M; Elson A
Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):114-123. PubMed ID: 30026076
[TBL] [Abstract][Full Text] [Related]
18. Surface expression of hemopoietic cell phosphatase fails to complement CD45 deficiency and inhibits TCR-mediated signal transduction in a Jurkat T cell clone.
Musci MA; Beaves SL; Ross SE; Yi T; Koretzky GA
J Immunol; 1997 Feb; 158(4):1565-71. PubMed ID: 9029091
[TBL] [Abstract][Full Text] [Related]
19. Receptor and nonreceptor protein tyrosine phosphatases in the nervous system.
Paul S; Lombroso PJ
Cell Mol Life Sci; 2003 Nov; 60(11):2465-82. PubMed ID: 14625689
[TBL] [Abstract][Full Text] [Related]
20. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
